UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Clinical cancer research, 2019-08, Vol.25 (15), p.4592-4602

2019

Volltextzugriff (PDF)

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer

Clinical cancer research, 2019-03, Vol.25 (5), p.1526-1534

2019

Volltextzugriff (PDF)

Objective measurement and clinical significance of TILs in non-small cell lung cancer

JNCI : Journal of the National Cancer Institute, 2015-03, Vol.107 (3), p.1

2015

Volltextzugriff (PDF)

Interleukin-8 in cancer pathogenesis, treatment and follow-up

Cancer treatment reviews, 2017-11, Vol.60, p.24-31

2017

Volltextzugriff (PDF)

Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?

Clinical cancer research, 2016-07, Vol.22 (14), p.3422-3424

2016

Volltextzugriff (PDF)

Oncolytic virus immunotherapy: future prospects for oncology

Journal for Immunotherapy of Cancer, 2018-12, Vol.6 (1), p.140-13, Article 140

2018

Volltextzugriff (PDF)

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Clinical cancer research, 2019-08, Vol.25 (15), p.4663-4673

2019

Volltextzugriff (PDF)

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer

Clinical cancer research, 2018-04, Vol.24 (7), p.1562-1573

2018

Volltextzugriff (PDF)

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.370-378

2017

Volltextzugriff (PDF)

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer

JAMA oncology, 2016-01, Vol.2 (1), p.46

2016

Volltextzugriff (PDF)

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

Breast cancer research : BCR, 2018-12, Vol.20 (1), p.154-154, Article 154

2018

Volltextzugriff (PDF)

Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)

Journal of thoracic oncology, 2013-06, Vol.8 (6), p.803-805

2013

Volltextzugriff (PDF)

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer

Modern pathology, 2017-03, Vol.30 (3), p.340-349

2017

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Journal of thoracic oncology, 2020-06, Vol.15 (6), p.914-947

2020

Volltextzugriff (PDF)

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.325-325, Article 325

2019

Volltextzugriff (PDF)

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer

Breast cancer research : BCR, 2016-07, Vol.18 (1), p.78-78, Article 78

2016

Volltextzugriff (PDF)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.65-65, Article 65

2019

Volltextzugriff (PDF)

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research

Clinical cancer research, 2016-05, Vol.22 (9), p.2102-2104

2016

Volltextzugriff (PDF)

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000155

2020

Volltextzugriff (PDF)

Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

Nature reviews. Clinical oncology, 2019-11, Vol.16 (11), p.703-715

2019

Volltextzugriff (PDF)

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic

Laboratory investigation, 2015-04, Vol.95 (4), p.385-396

2015

Volltextzugriff (PDF)

A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria

Archives of pathology & laboratory medicine (1976), 2014-02, Vol.138 (2), p.213-219

2014

Volltextzugriff (PDF)

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Journal for immunotherapy of cancer, 2022-06, Vol.10 (6), p.e004440

2022

Volltextzugriff (PDF)

Connexin 43 hemichannels mediate the Ca2+ influx induced by extracellular alkalinization

American Journal of Physiology: Cell Physiology, 2010-12, Vol.299 (6), p.C1504-C1515

2010

Volltextzugriff (PDF)

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

Nature communications, 2023-09, Vol.14 (1), p.5332-5332, Article 5332

2023

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(235)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(130)
Life Sciences & Biomedicine
(124)
Humans
(106)
Oncology
(87)
Immunotherapy
(49)
Female
(41)
Lung Cancer
(38)
Tumors
(37)
Biomarkers
(30)
Cancer
(30)
Male
(30)
Middle Aged
(30)
Aged
(28)
Lymphocytes
(25)
Animals
(24)
Immunology
(24)
Lung Neoplasms - Pathology
(22)
Proteins
(22)
Carcinoma, Non-Small-Cell Lung - Pathology
(20)
Patients
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes

Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer

Objective measurement and clinical significance of TILs in non-small cell lung cancer

Interleukin-8 in cancer pathogenesis, treatment and follow-up

Epithelial-Mesenchymal Transition and Immune Evasion during Lung Cancer Progression: The Chicken or the Egg?

Oncolytic virus immunotherapy: future prospects for oncology

Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis

Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers

Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)

Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Predictive Biomarkers for PD-1 Axis Therapies: The Hidden Treasure or a Call for Research

The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation

Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic

A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria

Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer

Connexin 43 hemichannels mediate the Ca2+ influx induced by extracellular alkalinization

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

Suchergebnisse filtern